Evaluating the impact of pharmacies on pandemic influenza vaccine administration

In this study, researchers from CDC and Battelle Memorial Institute in Atlanta sought to quantify the potential capacity of community pharmacy vaccine administration and its likely effect on pandemic influenza vaccine uptake.

In this study, researchers from CDC and Battelle Memorial Institute in Atlanta sought to quantify the potential capacity of community pharmacy vaccine administration and its likely effect on pandemic influenza vaccine uptake. They used software to create a discrete event simulation model to predict the potential effect of community pharmacy vaccine administration on total weekly vaccine administration and the time needed to reach 80% vaccination coverage with a single dose of vaccine per person. According to the data, weekly national vaccine administration capacity increased to 25 million doses per week when community pharmacist vaccination capacity was included in the model. Furthermore, assuming high public demand for vaccination, the time to achieve 80% vaccination coverage nationally was reduced by 7 weeks. The results for individual states varied, but the inclusion of pharmacies improved the time to target coverage in most states. The findings, conclude the authors, "support efforts to ensure pharmacist vaccinators are integrated into pandemic vaccine response planning."